Episurf Medical AB
STO:EPIS B
Relative Value
The Relative Value of one
EPIS B
stock under the Base Case scenario is
0.1486
SEK.
Compared to the current market price of 0.0394 SEK,
Episurf Medical AB
is
Undervalued by 73%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
EPIS B Competitors Multiples
Episurf Medical AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Episurf Medical AB
STO:EPIS B
|
65.4m SEK | 4.2 | -1 | -0.8 | -0.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.5B USD | 4.4 | 29.9 | 17 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178B USD | 17.7 | 62.4 | 47.6 | 57.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140.4B USD | 5.5 | 42.9 | 21.8 | 26.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.4B USD | 3.8 | 27.4 | 15.3 | 22.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD | 5.7 | 39.6 | 23.6 | 32.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.3B EUR | 2 | 21.8 | 12 | 17 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.7B USD | 12 | 48.8 | 34.9 | 38.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.8B USD | 2.2 | 29.2 | 11.2 | 19.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.2B USD | 7.7 | 33 | 23.4 | 25.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD | 7.2 | 26.3 | 18.6 | 20.7 |